Cormedix Inc (CRMD)
9.59
-0.40
(-4.00%)
USD |
NASDAQ |
Nov 04, 16:00
9.40
-0.19
(-1.98%)
After-Hours: 20:00
Cormedix Enterprise Value: 535.86M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 535.86M |
| November 01, 2024 | 560.14M |
| October 31, 2024 | 564.08M |
| October 30, 2024 | 563.78M |
| October 29, 2024 | 740.95M |
| October 28, 2024 | 778.57M |
| October 25, 2024 | 708.82M |
| October 24, 2024 | 675.82M |
| October 23, 2024 | 668.88M |
| October 22, 2024 | 650.93M |
| October 21, 2024 | 602.31M |
| October 18, 2024 | 591.31M |
| October 17, 2024 | 561.21M |
| October 16, 2024 | 558.89M |
| October 15, 2024 | 538.05M |
| October 14, 2024 | 536.31M |
| October 11, 2024 | 539.79M |
| October 10, 2024 | 517.21M |
| October 09, 2024 | 528.79M |
| October 08, 2024 | 513.74M |
| October 07, 2024 | 484.80M |
| October 04, 2024 | 469.17M |
| October 03, 2024 | 433.85M |
| October 02, 2024 | 432.70M |
| October 01, 2024 | 422.86M |
| Date | Value |
|---|---|
| September 30, 2024 | 421.70M |
| September 27, 2024 | 419.37M |
| September 26, 2024 | 429.76M |
| September 25, 2024 | 402.62M |
| September 24, 2024 | 388.18M |
| September 23, 2024 | 362.17M |
| September 20, 2024 | 366.64M |
| September 19, 2024 | 345.97M |
| September 18, 2024 | 359.10M |
| September 17, 2024 | 357.14M |
| September 16, 2024 | 348.76M |
| September 13, 2024 | 342.62M |
| September 12, 2024 | 337.59M |
| September 11, 2024 | 340.38M |
| September 10, 2024 | 302.40M |
| September 09, 2024 | 267.21M |
| September 06, 2024 | 276.14M |
| September 05, 2024 | 272.79M |
| September 04, 2024 | 275.03M |
| September 03, 2024 | 280.61M |
| August 30, 2024 | 302.96M |
| August 29, 2024 | 293.46M |
| August 28, 2024 | 290.67M |
| August 27, 2024 | 299.05M |
| August 26, 2024 | 304.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.06M
Minimum
Mar 18 2020
778.57M
Maximum
Oct 28 2024
157.38M
Average
132.59M
Median
Feb 03 2023
Enterprise Value Benchmarks
| Imunon Inc | 8.805M |
| Rockwell Medical Inc | 117.81M |
| Brainstorm Cell Therapeutics Inc | 6.099M |
| Outlook Therapeutics Inc | 143.29M |
| Aquestive Therapeutics Inc | 409.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.777M |
| Revenue (Quarterly) | 11.46M |
| Total Expenses (Quarterly) | 14.74M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 94.01% |
| Profit Margin (Quarterly) | -24.24% |
| Earnings Yield | -8.45% |
| Normalized Earnings Yield | -8.440 |